Case Study: Metabical
Problem Statement It is important to underline that the product had a tangible market. Metabical, a prescription obesity drug to be launched by CSP was quite different from other products in the market including those from CSP. First, it was set to be the first prescription drug for overweight people (BMI between 25-30) and had less side effects compared to substitutes. In addition, most overweight […]